Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma Limited has announced an earnings conference call for Q4 FY26 (quarter ending March 31, 2026). The call is scheduled for Friday, May 15, 2026 at 18:30 IST and will last 60 minutes. During the call, the management team will discuss the company's financial performance and business updates for the quarter and financial year ended March 31, 2026. The audio recording and transcript will be made available on the company's website after the call. This is a routine investor communication disclosure made to both BSE and NSE exchanges.
This is a standard quarterly disclosure providing an opportunity for investors and analysts to hear management's perspective on Q4 and full-year FY26 performance. The call itself is not a material event but offers important insights into the company's financial health and business outlook.